A 'danse macabre': tau and Fyn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity
- PMID: 23773061
- DOI: 10.1111/ejn.12251
A 'danse macabre': tau and Fyn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity
Abstract
Alzheimer's disease, with its two most prominent pathological factors amyloid beta and tau protein, can be described as a disease of the synapse. It therefore comes as little surprise that NMDA receptor-related synaptic dysfunction had been thought for several years to underlie the synaptic pathophysiology seen in Alzheimer's disease. In this review I will summarise recent evidence showing that the NMDA receptor links the effects of extracellular amyloid beta with intracellular tau protein. Furthermore, the antagonistic roles of Fyn and STEP in NMDA receptor regulation, synaptic plasticity and induction of synaptic depression will be discussed.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
Similar articles
-
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.Cell. 2010 Aug 6;142(3):387-97. doi: 10.1016/j.cell.2010.06.036. Epub 2010 Jul 22. Cell. 2010. PMID: 20655099
-
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.J Neurosci. 2011 Jan 12;31(2):700-11. doi: 10.1523/JNEUROSCI.4152-10.2011. J Neurosci. 2011. PMID: 21228179 Free PMC article.
-
Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.Mol Neurodegener. 2017 May 19;12(1):41. doi: 10.1186/s13024-017-0176-x. Mol Neurodegener. 2017. PMID: 28526038 Free PMC article.
-
Dysfunction of NMDA receptors in Alzheimer's disease.Neurol Sci. 2016 Jul;37(7):1039-47. doi: 10.1007/s10072-016-2546-5. Epub 2016 Mar 12. Neurol Sci. 2016. PMID: 26971324 Free PMC article. Review.
-
Fyn Kinase in Alzheimer's Disease: Unraveling Molecular Mechanisms and Therapeutic Implications.Mol Neurobiol. 2025 Jan;62(1):643-660. doi: 10.1007/s12035-024-04286-2. Epub 2024 Jun 18. Mol Neurobiol. 2025. PMID: 38890236 Review.
Cited by
-
Synaptic Compensatory Plasticity in Alzheimer's Disease.J Neurosci. 2023 Oct 11;43(41):6833-6840. doi: 10.1523/JNEUROSCI.0379-23.2023. J Neurosci. 2023. PMID: 37821232 Free PMC article. Review.
-
The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.PLoS One. 2018 Mar 5;13(3):e0193707. doi: 10.1371/journal.pone.0193707. eCollection 2018. PLoS One. 2018. PMID: 29505610 Free PMC article.
-
Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.Neurosci Res. 2014 Dec;89:1-9. doi: 10.1016/j.neures.2014.08.018. Epub 2014 Sep 10. Neurosci Res. 2014. PMID: 25218562 Free PMC article. Review.
-
Fyn Tyrosine Kinase as Harmonizing Factor in Neuronal Functions and Dysfunctions.Int J Mol Sci. 2020 Jun 22;21(12):4444. doi: 10.3390/ijms21124444. Int J Mol Sci. 2020. PMID: 32580508 Free PMC article. Review.
-
Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease.Nat Rev Neurosci. 2021 Dec;22(12):723-740. doi: 10.1038/s41583-021-00531-y. Epub 2021 Nov 1. Nat Rev Neurosci. 2021. PMID: 34725519 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous